Platform

Public evidence, vector-embedded for semantic search, with retrieval-augmented generation so an AI agent can compress complexity and surface benchmarks—built for fundraising and partnering conversations.

For founders raising capital · For teams who need BD visibility

The published record—queryable, composable, and ready when investors and partners ask hard questions on the spot.

Most of what convinces a sophisticated outsider already lives in public science and commercial literature—papers, patents, trial listings, labels where relevant, and the best third-party explainers. BioticaBio's platform treats that body of work as a first-class corpus: chunked, embedded into a vector index, and retrieved on demand so a language model can orient, synthesize, and contrast your program against benchmarks without asking your team to re-type the literature review every time a new VC or BD lead appears.

Why public-first, not “deal room only”

A classic data room is built for confidentiality. That matters at term sheet. But before you get there—and during the long tail of BD—outsiders are mostly trying to answer: What is the mechanism, what is validated, what is comparable, and why should I believe you can execute? Those answers are overwhelmingly assembled from what is already published. The platform is designed so your narrative and that public record reinforce each other: same concepts, same comparators, same trail of sources—so momentum builds instead of stalling on “send me another PDF.”

Retrieval-augmented generation (RAG)—in plain terms

We combine vector embeddings of your curated corpus with semantic retrieval: when someone asks a question, the system pulls the most relevant passages first, then a frontier model writes the answer from those passages. That is the standard definition of retrieval-augmented generation—the same pattern behind high-quality enterprise knowledge assistants, here tuned for scientific and commercial text instead of generic IT tickets.

In practice we use a managed vector store and retrieval API (e.g. OpenAI's vector file service and tool-based retrieval) so you spend less time wiring infrastructure and more time curating what belongs in the corpus—because the quality of the index is what separates a toy chatbot from something a serious scientist will trust in a live conversation.

What founders get in fundraising mode

  • Faster first meetings that don’t waste cycles. A partner or associate can interrogate mechanism, differentiation, and precedent programs against the same literature spine you care about—before they ever ask you for a bespoke memo.
  • One coherent story across channels. Your evidence-room pages, deck claims, and corpus-backed answers stay aligned on entities, indications, and comparators—so you are not accidentally telling three slightly different stories to three different firms.
  • Legibility without dilution. The goal is not to oversimplify the biology. It is to make complexity navigable—with paths from summary to supporting passages when the room wants depth.

What BD teams get in partnering mode

  • Benchmark and landscape pulls on demand. Comparator modalities, standard-of-care context, and “who else has tried this shape of claim” are exactly the questions that slow outbound—unless the retrieval layer is already warm.
  • Outbound that feels informed, not cold. When your team can cite the same public sources the counterparty already respects, you move from generic intros to specific, defensible hooks.
  • Internal alignment before external outreach. BD, med affairs, and founders can query the same corpus so messaging stays sharp across functions and time zones.

Built for credibility, not hype

The point of RAG is not “the model knows everything.” It is that the model is anchored to what you put in the index— published text, your public pages, and the boundaries you set. When you need clinical, regulatory, or partnering decisions, those still sit with your experts and counsel. The platform is here to compress search and synthesis so those experts spend fewer hours repeating the same literature tour—and more hours on judgment calls that actually move the deal.

Evidence for how buyers and allocators behave

Independent work on B2B evaluation, disclosure, and VC process—see tiered sources below. None of it replaces your obligation to be accurate; it explains why a public, well-structured narrative layer is commercially rational.